Female hormonal and reproductive factors and head and neck squamous cell carcinoma risk. Read more about Female hormonal and reproductive factors and head and neck squamous cell carcinoma risk.
Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: efficacy and underlying mechanisms. Read more about Cooperation of the HDAC inhibitor vorinostat and radiation in metastatic neuroblastoma: efficacy and underlying mechanisms.
Anti-tumor and radiosensitization activities of the iron chelator HDp44mT are mediated by effects on intracellular redox status. Read more about Anti-tumor and radiosensitization activities of the iron chelator HDp44mT are mediated by effects on intracellular redox status.
Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Read more about Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.
Histone deacetylase inhibitor induced modulation of anti-estrogen therapy. Read more about Histone deacetylase inhibitor induced modulation of anti-estrogen therapy.
Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer. Read more about Functional phenotyping and genotyping of circulating tumor cells from patients with castration resistant prostate cancer.
Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Read more about Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice.
Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU. Read more about Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU.
Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor. Read more about Trastuzumab decreases the number of circulating and disseminated tumor cells despite trastuzumab resistance of the primary tumor.
Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1. Read more about Regulation of hMSH2 and hMLH1 expression in the human colon cancer cell line SW1116 by DNA methyltransferase 1.
